JPMorgan Increases Stake in Polynovo Limited
JPMorgan Chase & Co. has increased its stake in Polynovo Limited (AU:PNV), raising its voting power from 7.53% to 9.06% as of April 14, 2025. This change reflects a notable shift in shareholder interest, potentially impacting company decisions. Polynovo Limited, operating in the medical device sector, has experienced a year-to-date price performance decline of 33.17%, with a current market cap of $484.7 million.
The latest update is out from Polynovo Limited ( (AU:PNV) ).
Polynovo Limited, a company in the medical device industry, has seen a change in the substantial holding of its shares by JPMorgan Chase & Co. and its affiliates. The voting power of JPMorgan has increased from 7.53% to 9.06% as of April 14, 2025, indicating a significant shift in shareholder interest and potential influence over company decisions.
More about Polynovo Limited
YTD Price Performance: -33.17%
Average Trading Volume: 4,406
Technical Sentiment Signal: Buy
Current Market Cap: $484.7M
Find detailed analytics on PNV stock on TipRanks’ Stock Analysis page.
Trending Articles:
- Meta’s Zuckerberg Weighed Instagram Spinoff, Fearing High-Profile Antitrust Trial
- Trump’s Executive Order on Healthcare Aims to Lower Drug Costs for Americans
- ‘Tariffs Are More Bark Than Bite,’ Says Investor About Apple Stock
Disclaimer & DisclosureReport an Issue
